CN111116672B - 一种靶向细胞核dna的铱配合物及其制备方法和用途 - Google Patents
一种靶向细胞核dna的铱配合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN111116672B CN111116672B CN201911361569.XA CN201911361569A CN111116672B CN 111116672 B CN111116672 B CN 111116672B CN 201911361569 A CN201911361569 A CN 201911361569A CN 111116672 B CN111116672 B CN 111116672B
- Authority
- CN
- China
- Prior art keywords
- nir
- iridium complex
- dna
- nuclear dna
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052741 iridium Inorganic materials 0.000 title claims abstract description 14
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 230000008685 targeting Effects 0.000 title claims abstract description 11
- 108091093105 Nuclear DNA Proteins 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 108020004414 DNA Proteins 0.000 title abstract description 20
- 102000053602 DNA Human genes 0.000 title abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000003384 imaging method Methods 0.000 claims description 10
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- ZMLMBJWTNOWQPF-UHFFFAOYSA-N 2H-1,10-phenanthroline-1,2-diamine Chemical compound NN1C(C=CC2=CC=C3C=CC=NC3=C12)N ZMLMBJWTNOWQPF-UHFFFAOYSA-N 0.000 claims description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 claims 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 claims 1
- 235000010703 Modiola caroliniana Nutrition 0.000 claims 1
- 244000038561 Modiola caroliniana Species 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000009987 spinning Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 24
- 210000003855 cell nucleus Anatomy 0.000 abstract description 13
- 230000011278 mitosis Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 210000004940 nucleus Anatomy 0.000 description 8
- MILUBEOXRNEUHS-UHFFFAOYSA-N iridium(3+) Chemical compound [Ir+3] MILUBEOXRNEUHS-UHFFFAOYSA-N 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 239000000975 dye Substances 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000010226 confocal imaging Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 238000000482 two photon fluorescence microscopy Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
技术领域
本发明涉及一种靶向细胞核DNA的铱配合物及其制备方法和用途,具有低毒性、水溶性、可实时观测细胞有丝分裂过程,能应用跟踪细胞核中的DNA以检测细胞是否癌变。
背景技术
细胞核作为真核细胞内最大的细胞器,控制着细胞的新陈代谢、遗传和增殖。其内部含有丰富的DNA,也即遗传信息的主要载体。因此,实时追踪细胞核内DNA动态过程在生命科学领域具有重要意义,受到科研工作者的广泛关注。目前常用的商业化细胞核染料DAPI、Hoechst等,大多是有机小分子,主要局限于单光子成像,同时伴随着水溶性差、细胞毒性大、光损伤大、光稳定性差等缺点,不利于长时间追踪,从而限制了这些染料在生物体内的应用和作用机理探究。此外,发射能量和激发能量间的斯托克斯位移小导致内源性荧光团的自发荧光而产生干扰。双光子荧光成像具有低能激发,高能发射,对细胞损伤小、高穿透性等特点。而近些年刚刚兴起的超分辨光学显微镜为在纳米分辨率的级别下观测细胞提供了可能。
铱(III)配合物由于其优良的磷光特性,如高的量子产量、大的斯托克斯位移、长寿命激发态、良好的抗光漂白性和卓越的发光波段可调特性等,作为荧光探针越来越广泛地应用于双光子及超分辨成像。铱(III)配合物的特性有利于靶向细胞核DNA,实时观测癌细胞分裂过程,跟踪细胞核中的DNA,避免遗传学上一些突变现象,具有重要的应用价值。据此,本发明设计合成了可用于双光子和超分辨成像具有细胞核DNA靶向性的铱(III)配合物。
发明内容
本发明提供了一种靶向细胞核DNA的铱配合物及其制备方法和用途,通过分子设计获得了一种铱配合物,具有低毒性、水溶性,可实时观测细胞有丝分裂过程,能应用跟踪细胞核中的DNA以检测细胞是否癌变。
本发明靶向细胞核DNA的铱配合物,简记为NIr,其结构式如下:
本发明铱配合物的制备方法,包括如下步骤:
在N2氛围下包裹锡箔纸的史莱克瓶中加入[Ir(L2)Cl]2(0.39g,0.2mmol)溶于混合溶剂50 mL(甲醇:二氯甲烷=25:25),再加9,10-双氨基邻菲罗啉(0.09g,0.44mmol),NaPF6(0.34g, 2.0mmol);升高温度至65℃,反应24h,冷却至室温,旋去溶剂,柱层析(二氯甲烷:甲醇=20:1)得到紫红色固体NIr。产量:0.17g,产率:32.4%。
其中,[Ir(L2)Cl]2的合成参见相关参考文献。
本发明合成路线如下:
本发明铱配合物的用途,是作为靶向细胞核DNA的荧光探针使用。
本发明铱配合物可以实时观测细胞有丝分裂过程,可在双光子和超分辨成像过程中作为检测试剂使用。
本发明有益效果体现在:
1、本发明合成的配合物NIr对细胞核DNA具有特异靶向性,灵敏度高、选择性好,RNA、蛋白质等不产生干扰,如图1、图5、图6所示。
2、NIr在近红外区(770nm)波长处双光子荧光信号最强,具有对细胞损伤小、高穿透性的特点,如图2所示。
3、NIr具有优异的光稳定性,极低的细胞毒性,可以实时观测细胞有丝分裂过程,如图 3、图4、图6所示。
4、NIr原料易得,合成简单。综合性质优于商用细胞核DNA染料,不存在类似的物质作为荧光探针,具有较强的商业价值。
附图说明
图1(a)NIr荧光发射光谱滴定图,随着DNA的加入,配合物的荧光强度明显增强,说明NIr对DNA具有高灵敏性。(b)NIr对DNA具有高选择性,对RNA,蛋白质等其他底物均无明显荧光响应,说明NIr高的选择性。
图2配合物NIr在细胞中的双光子荧光显影,图(a)说明NIr在690-810nm波长范围,显示出明显的双光子荧光信号,且能够很好的靶向细胞核。图(b)和图(c)说明NIr双光子最佳激发波长在近红外区(770nm),且在770nm波长处双光子荧光信号最强,双光子成像对生物体穿透性强,光损伤小。
图3为配合物NIr在HeLa细胞细内的荧光实时监测图。图(a)和(b)分别是5μM的NIr在37℃下孵育细胞24小时和6天,NIr依然能够着色细胞核,细胞的形态保存完好,说明NIr具有较低的细胞毒性,且能够稳定地靶向细胞核部位。
图4为NIr和细胞核商染在不同细胞分裂期的共聚焦显影情况。说明NIr和DAPI的着色部位和现象一致,即NIr可以靶向活细胞核内的DNA,且光稳定性好,能实时观察细胞核内DNA的动态过程。
图5为NIr在细胞中的TEM图。图(b)是被NIr作用的细胞,未用锇酸处理,作为对照;图(a)是被NIr作用的细胞,同时经过锇酸处理,两者对比,图(a)可以更加清楚地观察到亚细胞膜结构,包括线粒体、细胞膜和核膜。这些发现与共聚焦成像结果一致,说明了配合物NIr在活细胞的细胞核内高靶向性。
图6为NIr染色细胞核的受激发射损耗超分辨成像图。它的立体图、切面图以及立体深度图相辅相成,共同说明了NIr可以对细胞核进行高分辨成像,同时也说明NIr具有卓越的光稳定性、高穿透性和选择性。
具体实施方式
以下通过具体的实施例对本发明技术方案作进一步分析说明。
实施例1:
在N2氛围下包裹锡箔纸的史莱克瓶中加入[Ir(L2)Cl]2(0.39g,0.2mmol)溶于混合溶剂50 mL(甲醇:二氯甲烷=25:25),再加9,10-双氨基邻菲罗啉(0.09g,0.44mmol),NaPF6(0.34g, 2.0mmol);升高温度至65℃,反应24h,冷却至室温,旋去溶剂,柱层析(二氯甲烷:甲醇=20:1)得到紫红色固体NIr。产量:0.17g,产率:32.4%。ESI-MS:m/z:[M-3PF6 -]+:285.11 (calculated:285.11)。IR(KBr,cm-1):3637.41(m),3371.63(s),2924.39(w),1609.99(s),1588.81(w), 1566.54(w),1479.92(vs),1430.70(m),1373.45(m),1310.01(w),1270.94(m),1231.74(w), 841.49(vs),757.21(w),557.03(vs).1H NMR(400MHz,CD3CN-d3)δ=8.61(d,J=8.5,2H),8.15 (d,J=8.1,2H),8.08(d,J=4.8,2H),7.94(d,J=8.0,3H),7.88(t,J=8.0,2H),7.75(dd,J=8.5, 4.9,2H),7.45(d,J=5.6,2H),7.19(d,J=7.9,2H),6.97(t,J=6.6,2H),6.36(s,1H),4.81(s,4H), 4.14(dd,J=31.7,12.7,4H),2.88(s,18H).
实施例2:目标分子的生物学研究
1、利用激光共聚焦显微镜对NIr进行细胞成像研究。发现NIr在37℃下细胞中孵育30 min,展示出能够穿过细胞膜并对细胞核进行着色。
2、进一步研究NIr在细胞内的着色部位及细胞存活率,将5μM的NIr在37℃下分别孵育细胞24h和6d,NIr依然能够着色细胞核,从明场图中可以看出,细胞的形态保存完好,说明NIr具有较低的细胞毒性。NIr和细胞核商染DAPI在不同细胞分裂期的共聚焦显影实验表明,NIr着色的正在分裂的细胞的荧光较强,NIr和DAPI的着色部位一致,说明NIr可以靶向活细胞核内的DNA,且能够实时观察细胞核内DNA的动态。
参考文献:
Yi S.,Lu Z.,Zhang J.,Wang J.,Xie Z.,Hou L.Amphiphilic Gemini Iridium(III)Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imagingand Photodynamic Therapy,ACS Appl Mater Interfaces 2019:11:15276-15289。
Claims (6)
3.根据权利要求2所述的制备方法,其特征在于:
所述混合溶剂是由甲醇和二氯甲烷按体积比1:1构成。
4.根据权利要求2所述的制备方法,其特征在于:
柱层析分离的洗脱剂为二氯甲烷:甲醇=20:1,v/v。
5.一种权利要求1所述的铱配合物用于制备靶向细胞核DNA的荧光探针的用途。
6.根据权利要求5所述的用途,其特征在于:
所述荧光探针在双光子和超分辨成像过程中作为检测试剂使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911361569.XA CN111116672B (zh) | 2019-12-26 | 2019-12-26 | 一种靶向细胞核dna的铱配合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911361569.XA CN111116672B (zh) | 2019-12-26 | 2019-12-26 | 一种靶向细胞核dna的铱配合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111116672A CN111116672A (zh) | 2020-05-08 |
CN111116672B true CN111116672B (zh) | 2023-02-14 |
Family
ID=70502642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911361569.XA Active CN111116672B (zh) | 2019-12-26 | 2019-12-26 | 一种靶向细胞核dna的铱配合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111116672B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105694852A (zh) * | 2016-03-10 | 2016-06-22 | 安徽大学 | 一种邻菲罗啉钌配合物双光子吸收材料及其制备方法 |
CN109486235A (zh) * | 2018-11-10 | 2019-03-19 | 大连理工大学 | 一类具有细胞核靶向功能的dna染料化合物及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9505794B2 (en) * | 2014-10-08 | 2016-11-29 | Council Of Scientific And Industrial Research | Ruthenium (II) complexes, preparation and uses thereof |
-
2019
- 2019-12-26 CN CN201911361569.XA patent/CN111116672B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105694852A (zh) * | 2016-03-10 | 2016-06-22 | 安徽大学 | 一种邻菲罗啉钌配合物双光子吸收材料及其制备方法 |
CN109486235A (zh) * | 2018-11-10 | 2019-03-19 | 大连理工大学 | 一类具有细胞核靶向功能的dna染料化合物及应用 |
Non-Patent Citations (3)
Title |
---|
Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy;Sili Yi等;《ACS Appl. Mater. Interfaces》;20190410;第11卷;第15276-15289页 * |
Water-soluble phosphorescent iridium(III) complexes as multicolor probes for imaging of homocysteine and cysteine in living cells;Yun Ma等;《J. Mater. Chem.》;20111102;第21卷;第18974-18982页 * |
含苯基吡啶和吩嗪类配体的铱-稀土异金属配合物的合成及作为近红外发光DNA 探针;黄晓燕等;《科学通报》;20140411;第59卷(第17期);第1674-1680页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111116672A (zh) | 2020-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Ruthenium (II) anthraquinone complexes as two-photon luminescent probes for cycling hypoxia imaging in vivo | |
Liu et al. | A water-soluble two-photon ratiometric triarylboron probe with nucleolar targeting by preferential RNA binding | |
Luo et al. | A reversible ratiometric two-photon lysosome-targeted probe for real-time monitoring of pH changes in living cells | |
Ji et al. | A rhodamine-based “turn-on” fluorescent probe for Fe 3+ in aqueous solution | |
Wu et al. | A ratiometric fluorescent nanoprobe for H 2 O 2 sensing and in vivo detection of drug-induced oxidative damage to the digestive system | |
Li et al. | A near-infrared fluorescent probe for Cu2+ in living cells based on coordination effect | |
CN107325095A (zh) | 一种溶酶体次氯酸荧光探针及其制备方法和应用 | |
Liu et al. | A rhodamine chromene-based turn-on fluorescence probe for selectively imaging Cu2+ in living cell | |
CN112939935B (zh) | 一种用于溶酶体靶向荧光探针及其合成方法与细胞成像应用 | |
Yuan et al. | New switch on fluorescent probe with AIE characteristics for selective and reversible detection of mercury ion in aqueous solution | |
Guo et al. | Sensing for intracellular thiols by water-insoluble two-photon fluorescent probe incorporating nanogel | |
Dong et al. | A reversible frequency upconversion probe for real-time intracellular lysosome-pH detection and subcellular imaging | |
CN110981842A (zh) | 一种区分正常细胞和癌细胞的特异性检测脂滴的荧光探针及应用 | |
CN113087703A (zh) | 一种能特异性标记脂滴的光敏剂及其制备方法 | |
Li et al. | A photostable fluorescent probe for long-time imagining of lysosome in cell and nematode | |
CN113444071B (zh) | 一种细胞膜靶向的单线态氧发生器及其制备方法和用途 | |
CN110031436B (zh) | 一种检测脂滴的有机硅荧光探针 | |
CN114163463A (zh) | 一类针对肿瘤过程中过氧化氢实时变化的近红外荧光双光子荧光探针设计及其合成方法 | |
CN113354627B (zh) | 一种用于检测粘度的近红外荧光化合物及其制备与应用 | |
Ma et al. | Multiple cation-doped linear polymers toward ATP sensing and a cell imaging application | |
CN111116672B (zh) | 一种靶向细胞核dna的铱配合物及其制备方法和用途 | |
CN111533761B (zh) | 一类具有细胞器或蛋白质靶向功能的比率型pH探针及应用 | |
CN111334068B (zh) | 一种基于SNAP-tag技术的自闪烁超分辨荧光染料及其合成和应用 | |
CN108623611B (zh) | 一种检测过氧化氢的荧光探针的合成与应用 | |
Li et al. | A novel dual-capability naphthalimide-based fluorescent probe for Fe 3+ ion detection and lysosomal tracking in living cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |